Insights Into the Antigenic Repertoire of Unclassified Synaptic Antibodies
ABSTRACT Objective We sought to characterize the sixth most common finding in our neuroimmunological laboratory practice (tissue assay‐observed unclassified neural antibodies [UNAs]), combining protein microarray and phage immunoprecipitation sequencing (PhIP‐Seq). Methods Patient specimens (258; 133 serums; 125 CSF) meeting UNA criteria were profiled;
Michael Gilligan +22 more
wiley +1 more source
A large language model framework for literature-based disease-gene association prediction. [PDF]
Li PH +5 more
europepmc +1 more source
Mining for antimicrobial peptides in sequence space. [PDF]
Wan F, de la Fuente-Nunez C.
europepmc +1 more source
LexiSem: A re-ranker balancing lexical and semantic quality for enhanced abstractive summarization
Eman Aloraini +3 more
openalex +1 more source
O50: Multiscore, a gene ranker powered by artificial intelligence and real-world clinical data, shows high sensitivity in 10,000 exomes and genomes [PDF]
Vincent D. Ustach +14 more
openalex +1 more source
Network Localization of Fatigue in Multiple Sclerosis
ABSTRACT Background Fatigue is among the most common symptoms and one of the main factors determining the quality of life in multiple sclerosis (MS). However, the neurobiological mechanisms underlying fatigue are not fully understood. Here we studied lesion locations and their connections in individuals with MS, aiming to identify brain networks ...
Olli Likitalo +12 more
wiley +1 more source
Disentangling complex relationships and disjunctions in western Camassia: Integrating multiple criteria to resolve taxonomic boundaries. [PDF]
Kephart SR +5 more
europepmc +1 more source
Explain then Rank: Scale Calibration of Neural Rankers Using Natural Language Explanations from LLMs [PDF]
Puxuan Yu +4 more
openalex +1 more source
THE INFLUENCE OF LIMING THE RANKER SOIL TYPE WITH FLY-ASH OF KOSOVO POWERPLANTS, ON CHEMICAL AND PHYSICAL PROPERTIES [PDF]
A. Djikic +6 more
openalex +1 more source
Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin +2 more
wiley +1 more source

